Mather Group’s Boston Scientific BSX Stock Holding History

Mather Group’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$782K	Buy	17,915 +7,534	+73%	+$349K	0.01%	434
2026 Q2	$443K	Buy	10,381 +1,967	+23%	+$107K	﹤0.01%	568
2026 Q1	$528K	Sell	8,414 -89	-1%	-$7.12K	0.01%	472
2025 Q4	$811K	Buy	8,503 +757	+10%	+$74.2K	0.01%	319
2025 Q3	$756K	Sell	7,746 -1	-0%	-$104	0.01%	321
2025 Q2	$832K	Sell	7,747 -370	-5%	-$37.4K	0.01%	296
2025 Q1	$819K	Sell	8,117 -924	-10%	-$93K	0.01%	279
2024 Q4	$807K	Buy	9,041 +2,420	+37%	+$213K	0.01%	266
2024 Q3	$555K	Sell	6,621 -1,033	-13%	-$81.4K	0.01%	347
2024 Q2	$524K	Buy	7,654 +1,283	+20%	+$93.9K	0.01%	405
2024 Q1	$368K	Sell	6,371 -722	-10%	-$46.4K	0.01%	393
2023 Q4	$410K	Buy	7,093 +72	+1%	+$3.84K	0.01%	389
2023 Q3	$371K	Buy	7,021 +386	+6%	+$20.2K	0.01%	391
2023 Q2	$359K	Buy	+6,635	New	+$347K	0.01%	419

Other funds holding BSX

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

AMF Tjänstepension Stockholm, Sweden $17.2B AUM 28.3% 1-Year Est. Return

ZWJ Investment Counsel Atlanta, Georgia $3.24B AUM 31.6% 1-Year Est. Return

Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return

Gateway Investment Advisers Cincinnati, Ohio $11B AUM 34.31% 1-Year Est. Return

Gradient Investments Arden Hills, Minnesota $7B AUM 14.85% 1-Year Est. Return

MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return

Mather Group's BSX Position: Q3 2026 in Review

Mather Group increased its Boston Scientific (BSX) stake by 73% in Q3 2026, buying an estimated $349K and bringing the position to 17,915 shares worth $782K. The position accounts for 0.01% of the portfolio, ranked #434.

Mather Group first reported a position in BSX in Q2 2023 and has held it in 14 quarters since. The position peaked at $832K in Q2 2025. 308 funds tracked by Wall St. Rank hold BSX as of Q3 2026.

Mather Group held 17,915 shares of Boston Scientific worth $782K as of Q3 2026.
Mather Group bought 7,534 Boston Scientific shares in Q3 2026, an estimated $349K.
Boston Scientific made up 0.01% of Mather Group's portfolio in Q3 2026, its #434 holding.
Mather Group first reported a position in Boston Scientific in Q2 2023 and has held it in 14 quarters since.
Mather Group's Boston Scientific position peaked at $832K in Q2 2025.
308 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.

Based on Mather Group's 13F filing for Q3 2026, filed 14 Oct 2026.